Jody Tanabe
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance-Related Disorders | 18 | 2019 | 951 | 4.360 |
Why?
| Magnetic Resonance Imaging | 53 | 2021 | 3049 | 3.220 |
Why?
| Brain | 32 | 2021 | 2686 | 2.690 |
Why?
| Brain Mapping | 21 | 2019 | 605 | 2.250 |
Why?
| Cerebrovascular Circulation | 6 | 2021 | 186 | 2.050 |
Why?
| Nerve Net | 8 | 2019 | 259 | 2.030 |
Why?
| Cerebral Cortex | 14 | 2019 | 514 | 1.890 |
Why?
| Decision Making | 9 | 2017 | 774 | 1.690 |
Why?
| Prefrontal Cortex | 6 | 2017 | 326 | 1.670 |
Why?
| Image Processing, Computer-Assisted | 22 | 2019 | 725 | 1.650 |
Why?
| Acetates | 2 | 2021 | 106 | 1.590 |
Why?
| Impulsive Behavior | 7 | 2015 | 129 | 1.570 |
Why?
| Frontal Lobe | 7 | 2015 | 168 | 1.430 |
Why?
| Gambling | 5 | 2015 | 30 | 1.310 |
Why?
| Neuroimaging | 6 | 2021 | 210 | 1.250 |
Why?
| Thalamus | 4 | 2021 | 105 | 1.210 |
Why?
| Nicotine | 6 | 2013 | 264 | 1.170 |
Why?
| Limbic System | 4 | 2015 | 51 | 1.140 |
Why?
| Behavior | 3 | 2021 | 117 | 1.030 |
Why?
| Risk-Taking | 3 | 2015 | 365 | 1.020 |
Why?
| Substance Withdrawal Syndrome | 2 | 2019 | 175 | 0.980 |
Why?
| Nicotinic Agonists | 5 | 2011 | 126 | 0.940 |
Why?
| Learning | 2 | 2019 | 373 | 0.930 |
Why?
| Sex Characteristics | 4 | 2020 | 662 | 0.920 |
Why?
| Functional Neuroimaging | 2 | 2019 | 71 | 0.890 |
Why?
| Neostriatum | 2 | 2014 | 30 | 0.880 |
Why?
| Neuropsychiatry | 1 | 2020 | 11 | 0.880 |
Why?
| Pursuit, Smooth | 4 | 2005 | 26 | 0.870 |
Why?
| Alcoholism | 4 | 2021 | 801 | 0.810 |
Why?
| Psychomotor Performance | 5 | 2017 | 338 | 0.800 |
Why?
| Neural Pathways | 6 | 2017 | 317 | 0.800 |
Why?
| Reward | 2 | 2019 | 232 | 0.790 |
Why?
| Craving | 1 | 2019 | 27 | 0.780 |
Why?
| Transcranial Magnetic Stimulation | 1 | 2019 | 39 | 0.770 |
Why?
| Central Nervous System Depressants | 1 | 2019 | 116 | 0.740 |
Why?
| Drug Users | 2 | 2016 | 41 | 0.730 |
Why?
| Gray Matter | 2 | 2015 | 55 | 0.720 |
Why?
| Levodopa | 1 | 2017 | 37 | 0.680 |
Why?
| Antiparkinson Agents | 1 | 2017 | 33 | 0.680 |
Why?
| Parkinson Disease | 3 | 2017 | 412 | 0.680 |
Why?
| Sensation Disorders | 1 | 2017 | 37 | 0.660 |
Why?
| Tobacco Use Disorder | 1 | 2019 | 249 | 0.660 |
Why?
| Adult | 40 | 2021 | 31979 | 0.640 |
Why?
| Sexism | 1 | 2017 | 42 | 0.640 |
Why?
| Male | 57 | 2021 | 60993 | 0.610 |
Why?
| Neuropsychological Tests | 9 | 2016 | 1095 | 0.600 |
Why?
| Female | 57 | 2021 | 63035 | 0.600 |
Why?
| Ventral Striatum | 1 | 2015 | 10 | 0.580 |
Why?
| Functional Laterality | 3 | 2013 | 258 | 0.570 |
Why?
| Humans | 69 | 2021 | 113846 | 0.560 |
Why?
| Ethanol | 1 | 2019 | 714 | 0.550 |
Why?
| Attention | 4 | 2005 | 469 | 0.540 |
Why?
| Gyrus Cinguli | 5 | 2012 | 82 | 0.520 |
Why?
| Cognition | 2 | 2019 | 964 | 0.520 |
Why?
| Magnetic Resonance Angiography | 2 | 2009 | 220 | 0.510 |
Why?
| Conduct Disorder | 4 | 2017 | 198 | 0.510 |
Why?
| Patient Selection | 1 | 2017 | 694 | 0.500 |
Why?
| Cytokines | 1 | 2021 | 1981 | 0.490 |
Why?
| Hippocampus | 7 | 2015 | 795 | 0.480 |
Why?
| Schizophrenia | 6 | 2010 | 588 | 0.480 |
Why?
| Healthcare Disparities | 1 | 2017 | 465 | 0.450 |
Why?
| Inflammation | 1 | 2021 | 2451 | 0.400 |
Why?
| Veins | 1 | 2009 | 66 | 0.390 |
Why?
| Encephalitis, Varicella Zoster | 1 | 2008 | 20 | 0.380 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2015 | 264 | 0.380 |
Why?
| Spinal Cord Diseases | 1 | 2008 | 42 | 0.370 |
Why?
| Executive Function | 1 | 2013 | 374 | 0.370 |
Why?
| Reaction Time | 3 | 2013 | 487 | 0.350 |
Why?
| Cues | 4 | 2019 | 317 | 0.350 |
Why?
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 76 | 0.320 |
Why?
| Ganglionic Stimulants | 1 | 2005 | 12 | 0.310 |
Why?
| Analysis of Variance | 4 | 2013 | 1517 | 0.310 |
Why?
| Dementia, Vascular | 3 | 2000 | 15 | 0.310 |
Why?
| Pilot Projects | 2 | 2021 | 1421 | 0.300 |
Why?
| Evoked Potentials | 1 | 2005 | 161 | 0.280 |
Why?
| Middle Aged | 17 | 2021 | 28753 | 0.280 |
Why?
| Encephalitis, Herpes Simplex | 1 | 2003 | 21 | 0.270 |
Why?
| Ossification of Posterior Longitudinal Ligament | 1 | 2002 | 2 | 0.260 |
Why?
| Interview, Psychological | 2 | 2013 | 112 | 0.250 |
Why?
| Reference Values | 6 | 2021 | 877 | 0.250 |
Why?
| Herpesvirus 1, Human | 1 | 2003 | 85 | 0.250 |
Why?
| Thoracic Vertebrae | 1 | 2002 | 73 | 0.250 |
Why?
| Case-Control Studies | 5 | 2016 | 3369 | 0.240 |
Why?
| Adolescent Development | 2 | 2021 | 97 | 0.240 |
Why?
| Multimodal Imaging | 2 | 2019 | 110 | 0.230 |
Why?
| Administration, Oral | 2 | 2019 | 798 | 0.230 |
Why?
| Alcohol Abstinence | 1 | 2021 | 12 | 0.230 |
Why?
| Feedback, Psychological | 2 | 2013 | 27 | 0.220 |
Why?
| Amphetamine-Related Disorders | 2 | 2012 | 32 | 0.220 |
Why?
| Benzylidene Compounds | 2 | 2010 | 35 | 0.210 |
Why?
| Random Allocation | 1 | 2021 | 402 | 0.210 |
Why?
| Fingers | 2 | 2013 | 85 | 0.210 |
Why?
| Tremor | 2 | 2017 | 40 | 0.200 |
Why?
| Oxygen | 4 | 2017 | 892 | 0.200 |
Why?
| Vasculitis, Central Nervous System | 1 | 2019 | 16 | 0.200 |
Why?
| Cocaine-Related Disorders | 2 | 2012 | 112 | 0.200 |
Why?
| Photic Stimulation | 7 | 2017 | 224 | 0.200 |
Why?
| Psychiatric Status Rating Scales | 2 | 2015 | 559 | 0.190 |
Why?
| Cerebellum | 3 | 2013 | 246 | 0.190 |
Why?
| Administration, Intravenous | 1 | 2019 | 145 | 0.190 |
Why?
| Young Adult | 5 | 2019 | 10971 | 0.190 |
Why?
| Alzheimer Disease | 3 | 1998 | 420 | 0.180 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 1998 | 61 | 0.180 |
Why?
| Cross-Over Studies | 4 | 2013 | 484 | 0.170 |
Why?
| Selection Bias | 1 | 2017 | 32 | 0.170 |
Why?
| Positron-Emission Tomography | 1 | 2019 | 301 | 0.170 |
Why?
| Smoking | 3 | 2012 | 1632 | 0.160 |
Why?
| Artifacts | 3 | 2009 | 119 | 0.160 |
Why?
| DiGeorge Syndrome | 1 | 2016 | 21 | 0.160 |
Why?
| Pyridines | 2 | 2010 | 483 | 0.160 |
Why?
| Spinal Cord | 1 | 1998 | 406 | 0.150 |
Why?
| Organ Size | 3 | 2015 | 499 | 0.140 |
Why?
| Imaging, Three-Dimensional | 2 | 2009 | 557 | 0.140 |
Why?
| Postural Balance | 1 | 2017 | 201 | 0.140 |
Why?
| Problem Behavior | 1 | 2015 | 77 | 0.140 |
Why?
| Single-Blind Method | 2 | 2012 | 280 | 0.130 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2013 | 35 | 0.130 |
Why?
| Nucleus Accumbens | 1 | 2015 | 145 | 0.130 |
Why?
| Longitudinal Studies | 2 | 2021 | 2692 | 0.130 |
Why?
| Surveys and Questionnaires | 3 | 2013 | 4625 | 0.130 |
Why?
| Age Factors | 1 | 2021 | 3330 | 0.130 |
Why?
| Alcohol Drinking | 1 | 2019 | 721 | 0.120 |
Why?
| Heroin Dependence | 1 | 2012 | 31 | 0.120 |
Why?
| Personality Inventory | 1 | 2013 | 158 | 0.120 |
Why?
| Brain Ischemia | 3 | 2000 | 267 | 0.120 |
Why?
| Principal Component Analysis | 1 | 2013 | 182 | 0.120 |
Why?
| Emotions | 1 | 2017 | 428 | 0.120 |
Why?
| Aged | 11 | 2017 | 20109 | 0.120 |
Why?
| Adolescent Behavior | 1 | 2017 | 515 | 0.120 |
Why?
| Efficiency | 1 | 2012 | 97 | 0.120 |
Why?
| Susac Syndrome | 1 | 2011 | 4 | 0.110 |
Why?
| Appetite Regulation | 1 | 2011 | 34 | 0.110 |
Why?
| Research Design | 1 | 2017 | 913 | 0.110 |
Why?
| Fatal Outcome | 2 | 2019 | 314 | 0.110 |
Why?
| Cognition Disorders | 2 | 2010 | 584 | 0.110 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 76 | 0.110 |
Why?
| Inpatients | 1 | 2014 | 335 | 0.110 |
Why?
| Cerebrospinal Fluid | 2 | 2003 | 95 | 0.100 |
Why?
| Comorbidity | 1 | 2015 | 1601 | 0.100 |
Why?
| Regression Analysis | 1 | 2013 | 1137 | 0.100 |
Why?
| Visual Perception | 1 | 2011 | 162 | 0.100 |
Why?
| Atrophy | 5 | 2007 | 140 | 0.100 |
Why?
| Socioeconomic Factors | 1 | 2014 | 1211 | 0.100 |
Why?
| Adolescent | 9 | 2021 | 18736 | 0.100 |
Why?
| Nerve Fibers, Unmyelinated | 1 | 2008 | 9 | 0.100 |
Why?
| Sex Factors | 1 | 2015 | 1997 | 0.100 |
Why?
| Temperance | 1 | 2008 | 18 | 0.100 |
Why?
| Nutritional Status | 1 | 2011 | 282 | 0.100 |
Why?
| Disease Progression | 2 | 2008 | 2489 | 0.090 |
Why?
| Magnetic Resonance Spectroscopy | 3 | 2000 | 529 | 0.090 |
Why?
| Wechsler Scales | 1 | 2007 | 70 | 0.090 |
Why?
| Chewing Gum | 1 | 2007 | 9 | 0.090 |
Why?
| Eye Movements | 2 | 2010 | 70 | 0.090 |
Why?
| Energy Intake | 1 | 2011 | 493 | 0.090 |
Why?
| Receptors, Nicotinic | 1 | 2010 | 335 | 0.090 |
Why?
| Alcohols | 1 | 2007 | 35 | 0.090 |
Why?
| Event-Related Potentials, P300 | 2 | 2004 | 21 | 0.080 |
Why?
| Alcohol-Related Disorders | 1 | 2008 | 120 | 0.080 |
Why?
| Exploratory Behavior | 1 | 2007 | 108 | 0.080 |
Why?
| Parietal Lobe | 2 | 2005 | 61 | 0.080 |
Why?
| Normal Distribution | 1 | 2006 | 22 | 0.080 |
Why?
| Evoked Potentials, Visual | 2 | 2002 | 40 | 0.080 |
Why?
| Rod Cell Outer Segment | 1 | 1985 | 2 | 0.080 |
Why?
| Color Vision Defects | 1 | 1985 | 7 | 0.080 |
Why?
| Photoreceptor Cells | 1 | 1985 | 13 | 0.080 |
Why?
| Diagnosis, Differential | 2 | 2003 | 1432 | 0.080 |
Why?
| Dissociative Disorders | 1 | 2005 | 24 | 0.080 |
Why?
| Models, Neurological | 1 | 2007 | 242 | 0.080 |
Why?
| Spinal Nerve Roots | 1 | 2005 | 34 | 0.070 |
Why?
| Double-Blind Method | 2 | 2009 | 1673 | 0.070 |
Why?
| Cranial Nerve Diseases | 1 | 2005 | 45 | 0.070 |
Why?
| Aged, 80 and over | 5 | 1999 | 6796 | 0.070 |
Why?
| Taste | 1 | 2007 | 267 | 0.070 |
Why?
| Aspartic Acid | 3 | 2000 | 89 | 0.070 |
Why?
| Peripheral Nervous System Diseases | 1 | 2005 | 142 | 0.070 |
Why?
| Electroencephalography | 2 | 2003 | 499 | 0.070 |
Why?
| Ocular Motility Disorders | 1 | 2004 | 29 | 0.070 |
Why?
| Aphasia | 1 | 2003 | 24 | 0.070 |
Why?
| Endothelium, Vascular | 1 | 2011 | 973 | 0.070 |
Why?
| Temporal Lobe | 1 | 2003 | 94 | 0.060 |
Why?
| Echo-Planar Imaging | 1 | 2002 | 19 | 0.060 |
Why?
| Pattern Recognition, Visual | 1 | 2004 | 116 | 0.060 |
Why?
| Heart Rate | 1 | 2007 | 844 | 0.060 |
Why?
| Mental Processes | 1 | 2002 | 38 | 0.060 |
Why?
| Fourier Analysis | 1 | 2002 | 40 | 0.060 |
Why?
| Treatment Outcome | 2 | 2014 | 9002 | 0.060 |
Why?
| Nerve Fibers, Myelinated | 2 | 2005 | 49 | 0.060 |
Why?
| Decompression, Surgical | 1 | 2002 | 89 | 0.060 |
Why?
| Stroke | 2 | 2019 | 930 | 0.060 |
Why?
| Liver Diseases | 1 | 2003 | 270 | 0.060 |
Why?
| Tomography, X-Ray Computed | 2 | 2019 | 2380 | 0.050 |
Why?
| Multiple Sclerosis | 1 | 2005 | 325 | 0.050 |
Why?
| Memory, Short-Term | 1 | 2004 | 268 | 0.050 |
Why?
| Motor Activity | 1 | 2006 | 756 | 0.050 |
Why?
| Incidental Findings | 1 | 2021 | 81 | 0.050 |
Why?
| Polymerase Chain Reaction | 1 | 2003 | 1100 | 0.050 |
Why?
| Seizures | 1 | 2003 | 339 | 0.050 |
Why?
| Blood Pressure | 1 | 2007 | 1761 | 0.050 |
Why?
| Indocyanine Green | 1 | 2019 | 13 | 0.050 |
Why?
| Ophthalmoscopy | 1 | 2019 | 25 | 0.050 |
Why?
| Psychotic Disorders | 1 | 2005 | 293 | 0.050 |
Why?
| Cerebral Infarction | 1 | 1999 | 46 | 0.050 |
Why?
| Coloring Agents | 1 | 2019 | 77 | 0.050 |
Why?
| Algorithms | 1 | 2007 | 1558 | 0.050 |
Why?
| Optical Imaging | 1 | 2019 | 59 | 0.050 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2019 | 138 | 0.050 |
Why?
| Kidney Failure, Chronic | 1 | 2003 | 441 | 0.050 |
Why?
| Tomography, Optical Coherence | 1 | 2019 | 138 | 0.040 |
Why?
| Brain Chemistry | 1 | 1998 | 158 | 0.040 |
Why?
| Blood Flow Velocity | 1 | 1999 | 378 | 0.040 |
Why?
| Obesity | 1 | 2011 | 2627 | 0.040 |
Why?
| Visual Acuity | 1 | 2019 | 250 | 0.040 |
Why?
| Cerebral Ventricles | 1 | 1997 | 54 | 0.040 |
Why?
| Animals | 1 | 2019 | 35394 | 0.040 |
Why?
| Motor Neurons | 1 | 1998 | 215 | 0.040 |
Why?
| Referral and Consultation | 1 | 2021 | 635 | 0.040 |
Why?
| Empathy | 1 | 2017 | 125 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 2 | 2010 | 2229 | 0.040 |
Why?
| Gait Disorders, Neurologic | 1 | 2015 | 38 | 0.040 |
Why?
| Child | 3 | 2021 | 17711 | 0.030 |
Why?
| Age of Onset | 1 | 2016 | 494 | 0.030 |
Why?
| Glucose | 1 | 1999 | 887 | 0.030 |
Why?
| Hyperphagia | 1 | 2011 | 33 | 0.030 |
Why?
| Sensation | 1 | 2011 | 43 | 0.030 |
Why?
| Labor, Induced | 1 | 2011 | 31 | 0.030 |
Why?
| Cohort Studies | 1 | 2021 | 5011 | 0.030 |
Why?
| Thinness | 1 | 2011 | 92 | 0.030 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 100 | 0.030 |
Why?
| Cyclophosphamide | 1 | 2011 | 238 | 0.030 |
Why?
| Rituximab | 1 | 2011 | 162 | 0.030 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2010 | 126 | 0.030 |
Why?
| Fasting | 1 | 2011 | 280 | 0.020 |
Why?
| Food | 1 | 2011 | 163 | 0.020 |
Why?
| Immunoglobulins, Intravenous | 1 | 2011 | 150 | 0.020 |
Why?
| Creatine | 2 | 2000 | 47 | 0.020 |
Why?
| Hemodynamics | 1 | 2013 | 1099 | 0.020 |
Why?
| Aspirin | 1 | 2011 | 317 | 0.020 |
Why?
| Dominance, Cerebral | 1 | 2007 | 69 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2011 | 1004 | 0.020 |
Why?
| Nerve Fibers | 1 | 2007 | 79 | 0.020 |
Why?
| Adrenal Cortex Hormones | 1 | 2011 | 492 | 0.020 |
Why?
| Cranial Nerves | 1 | 2005 | 11 | 0.020 |
Why?
| Sural Nerve | 1 | 2005 | 19 | 0.020 |
Why?
| Weight Loss | 1 | 2011 | 694 | 0.020 |
Why?
| Graves Disease | 1 | 2005 | 29 | 0.020 |
Why?
| Hypertrophy | 1 | 2005 | 120 | 0.020 |
Why?
| Visual Pathways | 1 | 2005 | 43 | 0.020 |
Why?
| Genotype | 1 | 2010 | 2074 | 0.020 |
Why?
| Treatment Failure | 1 | 2005 | 329 | 0.020 |
Why?
| Area Under Curve | 1 | 2005 | 328 | 0.020 |
Why?
| Schizophrenic Psychology | 1 | 2005 | 134 | 0.020 |
Why?
| Visual Fields | 1 | 2004 | 81 | 0.020 |
Why?
| Myelin Sheath | 1 | 2005 | 130 | 0.020 |
Why?
| Axons | 1 | 2005 | 177 | 0.020 |
Why?
| Genetic Linkage | 1 | 2005 | 364 | 0.020 |
Why?
| Genetic Markers | 1 | 2005 | 402 | 0.020 |
Why?
| Early Diagnosis | 1 | 2005 | 251 | 0.020 |
Why?
| Head | 1 | 2004 | 77 | 0.020 |
Why?
| Gene Frequency | 1 | 2005 | 572 | 0.020 |
Why?
| Visual Cortex | 1 | 2002 | 41 | 0.020 |
Why?
| Neural Inhibition | 1 | 2004 | 175 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2010 | 2052 | 0.020 |
Why?
| Movement | 1 | 2004 | 274 | 0.010 |
Why?
| Immunosuppressive Agents | 1 | 2005 | 676 | 0.010 |
Why?
| Risk | 1 | 2004 | 943 | 0.010 |
Why?
| Tomography, Emission-Computed | 1 | 1999 | 100 | 0.010 |
Why?
| Pregnancy | 1 | 2011 | 5290 | 0.010 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 104 | 0.010 |
Why?
| Protons | 1 | 1997 | 74 | 0.010 |
Why?
| Choline | 1 | 1998 | 115 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2004 | 2424 | 0.010 |
Why?
| Biomarkers | 1 | 2005 | 3501 | 0.010 |
Why?
| Severity of Illness Index | 1 | 1999 | 2828 | 0.010 |
Why?
|
|
Tanabe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|